Cytomorphological features of ALK-positive pulmonary adenocarcinoma with abundant psammoma bodies.

Advanced Search

Nada Shaker, Nuha Shaker, Abdul Abid, Isabella M Tynski, Zofia Tynski, Anil Parwani

Author Information

Nada Shaker: Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA. ORCID
Nuha Shaker: Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
Abdul Abid: Department of Pathology, University of Virginia Health, Charlottesville, Virginia, USA.
Isabella M Tynski: The Ohio State University, Columbus, Ohio, USA.
Zofia Tynski: Department of Pathology, Fairfield Medical Center, Lancaster, Ohio, USA.
Anil Parwani: Anatomic Pathology, Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.

PMID: 37534826 DOI: 10.1002/dc.25208

No abstract text available.

Cardisciani L, Policardo F, Tralongo P, Fiorentino V, Rossi ED. What psammoma bodies can represent in the thyroid. What we recently learnt from a story of lack of evidence. Pathologica. 2022;114(5):373-375. doi:10.32074/1591-951X-815

Motohara T, Tashiro H, Miyahara Y, Sakaguchi I, Ohtake H, Katabuchi H. Long-term oncological outcomes of ovarian serous carcinomas with psammoma bodies: a novel insight into the molecular pathogenesis of ovarian epithelial carcinoma. Cancer Sci. 2010;101(6):1550-1556. doi:10.1111/j.1349-7006.2010.01556.x

Schneider NI, Bauernhofer T, Schöllnast H, Ott A, Langner C. Pancreatic adenocarcinoma with multiple eosinophilic extracellular deposits consistent with noncalcified psammoma bodies. Virchows Arch Int J Pathol. 2011;459(6):623-625. doi:10.1007/s00428-011-1159-x

Parkash V, Carcangiu ML. Endometrioid endometrial adenocarcinoma with psammoma bodies. Am J Surg Pathol. 1997;21(4):399-406. doi:10.1097/00000478-199704000-00005

Chumbalkar V, Wang P, Paner GP. Spectrum of biphasic renal cell carcinomas with hyalinized stroma and psammoma bodies associated and not associated with NF2 alteration. Hum Pathol. 2022;121:11-18. doi:10.1016/j.humpath.2021.12.001

Park SY, Ko GH, Kim WH, Kim YI. Papillary adenocarcinoma of the stomach with psammoma bodies: report of two cases. J Korean Med Sci. 1999;14(2):213-216. doi:10.3346/jkms.1999.14.2.213

Zhang XP, Jiang GY, Zhang QF, Xu HT, Li QC, Wang EH. Primary acinic cell carcinoma of the lung with psammoma bodies: a case report and review of literature. Pathol Res Pract. 2017;213(4):405-409. doi:10.1016/j.prp.2017.01.011

Unterman DH, Reingold IM. The occurrence of psammoma bodies in papillary adenocarcinoma of the lung. Am J Clin Pathol. 1972;57(3):297-302. doi:10.1093/ajcp/57.3.297

Chen KT. Psammoma bodies in fine-needle aspiration cytology of papillary adenocarcinoma of the lung. Diagn Cytopathol. 1990;6(4):271-274. doi:10.1002/dc.2840060409

Martínez-Girón R, Martínez-Torre S, Tamargo-Peláez ML, López-Cabanilles MD, Torre-Bayón C. Calcareous concretions and psammoma bodies in sputum smears: do these similar structures have different clinical significance? Diagn Cytopathol. 2014;42(9):759-765. doi:10.1002/dc.23120

Miyake A, Okudela K, Matsumura M, et al. Update on the potential significance of psammoma bodies in lung adenocarcinoma from a modern perspective. Histopathology. 2018;72(4):609-618. doi:10.1111/his.13397

Miyoshi I, Kubota T, Saito T, et al. Psammoma bodies in lung cancer. Intern Med Tokyo Jpn. 2006;45(5):335-336. doi:10.2169/internalmedicine.45.1517

Sasou S, Takayama K, Iwasaki T, Suzuki T, Nemoto Y. Crystals and psammoma bodies in adenocarcinoma of the lung. Gan No Rinsho Jpn J Cancer Clin. 1986;32(5):520-524.

Trisolini R, Cancellieri A, Livi V, et al. Pulmonary adenocarcinoma with psammoma bodies is associated with a specific endobronchial ultrasound pattern and a high prevalence of actionable driver mutations. Lung Cancer. 2020;147:204-208. doi:10.1016/j.lungcan.2020.07.025

Pareja F, Crapanzano JP, Mansukhani MM, Bulman WA, Saqi A. Cytomorphological features of ALK-positive lung adenocarcinomas: psammoma bodies and signet ring cells. Cancer Cytopathol. 2015;123(3):162-170. doi:10.1002/cncy.21507

Paulk A, Tavora F, Burke A. Pulmonary mucinous adenocarcinomas: a clinicopathologic series with emphasis on the prognostic significance of spread through alveolar spaces, and presence of solid growth component. Surg Exp Pathol. 2018;1(1):3. doi:10.1186/s42047-018-0013-8

Türüt H, Demirag F, Gulhan E, Tastepe İ. Primary pulmonary mucinous adenocarcinoma in a 15-year-old boy. Eur J Cardiothorac Surg. 2006;29(5):851-853. doi:10.1016/j.ejcts.2006.01.051

Grosse A, Grosse C. Lung adenocarcinoma manifesting with lymphangitic spread and psammoma bodies, harboring a HER2 exon 20 insertion mutation (p.A745_G746insYVMA). J Thorac Oncol. 2019;14(3):e52-e54. doi:10.1016/j.jtho.2018.11.024

Mukhopadhyay S, Pennell NA, Ali SM, Ross JS, Ma PC, Velcheti V. RET-rearranged lung adenocarcinomas with lymphangitic spread, psammoma bodies, and clinical responses to cabozantinib. J Thorac Oncol. 2014;9(11):1714-1719. doi:10.1097/JTO.0000000000000323

/Ohio State University

Journal Article

OpenLB
Open Library of Bioscience